Capital World Investors 13D and 13G filings for AbCellera Biologics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 2:49 pm Sale | 2023-02-14 | 13G | AbCellera Biologics Inc. ABCL | Capital World Investors | 9,327,493 3.300% | -12,724,210 (-57.70%) | Filing |
| 2022-02-11 2:48 pm Purchase | 2022-02-14 | 13G | AbCellera Biologics Inc. ABCL | Capital World Investors | 22,051,703 7.800% | 22,051,703 (New Position) | Filing |